Loading company…
Riskpilot
← Back to search
Sign in
Get full access
MR Jakobsen Holding ApS
APS
Active
CVR 39143186
Kanehaven 33
Activities of holding companies · NACE 6421
Est. 2017
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK 432K
+227% vs 2023
EBITDA margin
100.0%
+227% vs 2023
Equity ratio
71.3%
Financial strength
Net profit 2024
DKK 331K
+205% vs 2023
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
DKK 432K
+227%
EBITDA
DKK 432K
+227%
Net profit
DKK 331K
+205%
Total assets
DKK 617K
+56%
Equity
DKK 440K
+303%
Employees
—
—
Company information
Legal name
MR Jakobsen Holding ApS
CVR number
39143186
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
6. december 2017
Share capital
DKK 50.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren.
Company purpose
Selskabets formål er besiddelse kapitalandele i andre selskaber samt konsulent- og foredragsvirksomhed.
Contact
Address
Kanehaven 33
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Activities of holding companies
Companies in Aarhus
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Revenue
-7
-10
-8
132
432
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-7
-10
-8
132
432
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-7
-10
-8
132
432
Net financials
-0
-4
-3
-4
-8
Profit before tax
-7
-14
-12
128
424
Tax
-0
-0
-0
20
94
Net profit
-7
-14
-12
108
331
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
1.556
98
101
396
617
Equity
26
12
1
109
440
Long-term debt
0
0
0
0
0
Short-term debt
1.529
85
100
287
177
Total debt
1.529
85
100
287
177
Financial ratios
5-year trend
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
2020
2024
Equity ratio
71.3%
This company
38.2%
Market median
+87% vs market
2020
2024
Return on equity
75.2%
This company
18.4%
Market median
+309% vs market
2020
2024
Net profit margin
76.5%
This company
8.1%
Market median
+844% vs market
2020
2024
Asset turnover
0.70×
This company
1.12×
Market median
-38% vs market
2020
2024
Debt / equity
0.40×
This company
0.62×
Market median
+35% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Martin Roelsgaard Jakobsen
Individual
66.67–89.99%
66.67–89.99%
2017
Frederik Roelsgaard Madsen
Individual
10–14.99%
10–14.99%
2018
Andreas Roelsgaard Madsen
Individual
10–14.99%
10–14.99%
2018
Signe Roelsgaard Madsen
Individual
10–14.99%
10–14.99%
2018
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
MR Jakobsen Holding ApS
(this company)
Sulis Therapeutics ApS
STIPE Therapeutics ApS
UNIKUM Therapeutics ApS
Board network connections
Board members of MR Jakobsen Holding ApS also hold positions in
0
other companies.
Person
Role here
Other companies